Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

CompletedOBSERVATIONAL
Enrollment

3,434

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic Hepatitis B
Trial Locations (54)

17000

Local Institution, Ordos

30000

Local Institution, Taiyuan

55000

Local Institution, Guiyang

100050

Local Institution, Beijing

110006

Local Institution, Shenyang

113000

Local Instution, Fushun

116001

Local Institution, Dalian

130000

Local Institution, Changchun

133000

Local institution, Yanji

150086

Local Institution, Haerbin

163461

Local Institution, Daqing

210000

Local Institution, Nanjing

213001

Local Institution, Changzhou

215000

Local Institution, Suzhou

215500

Local Institution, Changshu

250000

Local Institution, Jinan

264001

Local Institution, Yantai

266000

Local Institution, Qingdao

300000

Local Institution, Tianjin

Local Institution, Jinghua

310000

Local institution, Hangzhou

310006

Local Institution, Hangzhou

310023

Local Institution, Hangzhou

315010

Local Institution, Ningbo

330006

Local Institution, Nangchang

350000

Local Institution, Fuzhou

362002

Local Institution, Quanzhou

400038

Local Institution, Chongqing

410006

Local Institution, Changsha

410008

Local Institution, Changsha

410013

Local Institution, Changsha

430000

Local Institution, Zhengzhou

Local Institution, Shiyan

430022

Local Institution, Wuhan

430032

Local Institution, Wuhan

450000

Local Institution, Zhengzhou

528000

Local Institution, Foshan

Local Institution, Shenzhen

530000

Local Institution, Nanning

550000

Local institution, Guiyang

570100

Local Institution, Haikou

610041

Local Institution, Chengdu

610072

Local Institution, Chengdu

710032

Local Institution, Chongqing

Local Institution, Xi’an

710061

Local Institution, Xi’an

750000

Local Institution, Yinchuan

830001

Local Institution, Ürümqi

830052

Local Institution, Ürümqi

1361009

Local Institution, Xiamen

071000

Local Institution, Baoding

050000

Local Institution, Shijiazhuang

Unknown

Local Institution, Shengyang

030000

Local Institution, Taiyuan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01726439 - Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China | Biotech Hunter | Biotech Hunter